AlphaYouRS
Insider selling
Ryan Savitz sold $3.2M of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock
Ryan Savitz, EVP, CFO & Cbo of Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 31,249 shares of DNTH stock worth $3.2M, per an SEC Form 4 filed Jul 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 9, 2026, 4 days before it was made public.
DNTH has moved -3.6% since the trade date, from $100.03 to $96.47 (Sep 21, 2026 close).
- Traded
- Jul 9, 2026
- Disclosed
- Jul 13, 2026
- Filing delay
- 4 days
- Price since
- -3.6%
- Role
- EVP, CFO & Cbo
- Source
- SEC Form 4
More DNTH insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.